One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Issue Highlights page
doi : 10.1016/S0360-3016(21)03186-2
Volume 112, Issue 2, 1 February 2022, Pages A10-A12
Targeting PARP for Chemoradiosensitization: Opportunities, Challenges, and the Road Ahead
HenningWillersMD*MechthildKrauseMD†CorinneFaivre-FinnMD, PhD‡Anthony J.ChalmersMD, PhD§
Logistic Regression in Clinical Studies
Emily C.ZaborDrPH*‡Chandana A.ReddyMS†‡Rahul D.TendulkarMD†‡SujataPatilPhD*‡
Trim One’s (E)Wings—How Much is Enough?
Boryana M.EastmanMD, PhDGabrielle M.KaneMD
Tipping the Scales Toward Single Modality
Stephanie K.SchaubMD1Catherine M.AlbertMD2
Tilting the Balance, and Gantry, Towards Preservation of Function
Matthew B.SprakerMD, PhD1Mia C.WeissMD2
Extraosseous, Always Personal
Krisha J.HowellMD(Associate Professor)
Canadian Perspectives on Radiation Oncologist Workforce Planning and the Job Market
DanaKeiltyMDCM, MSc*NaumanMalikMD*JolieRingashMD*RossHalperinMD†MichaelBrundageMD‡Corinne M.DollMD§Shaun K.LoewenPhD, MD§
Disparities in Access to Radiation Therapy Facilities Among American Indians/Alaska Natives and Hispanics in Washington State
Matthew D.GreerMD�SolmazAmiriDDes†‡Justin T.DenneyPhD§OferAmramPhD†Lia M.HalaszMD*DedraBuchwaldMD‡
Adding Short-Term Androgen Deprivation Therapy to Radiation Therapy in Men With Localized Prostate Cancer: Long-Term Update of the NRG/RTOG 9408 Randomized Clinical Trial
Christopher U.JonesMD*Stephanie L.PughPhD†Howard M.SandlerMD‡Michael P.ChetnerMD§Mahul B.AminMD║Deborah W.BrunerPhD¶Anthony L.ZietmanMD#Robert B.DenMD��Mark H.LeibenhautMD*John M.LongoMD††Jean-PaulBaharyMD‡‡Seth A.RosenthalMD*LuisSouhamiMD§§Jeff M.MichalskiMD║║Alan C.HartfordMD¶¶Pradip P.AminMD##MackRoachIIIMD���DonYeeMD†††…William U.ShipleyMD#
Androgen Deprivation Therapy, Perseverance, and Greek Mythology
AlisonTreeMD(Res)
Parotid Gland Stem Cell Sparing Radiation Therapy for Patients With Head and Neck Cancer: A Double-Blind Randomized Controlled Trial
Roel J.H.M.SteenbakkersMD, PhD�Maria I.van Rijn–DekkerMD*Monique A.StokmanPhD*Roel G.J.KierkelsPhD†Arjenvan der SchaafPhD*Johanna G.M.van den HoekMD*Hendrik P.BijlMD, PhD*Maria C.A.KramerMD, PhD*Robert P.CoppesPhD�‡Johannes A.LangendijkMD, PhD*Petervan LuijkPhD�
Radiation Therapy Across Pediatric Hodgkin Lymphoma Research Group Protocols: A Report From the Staging, Evaluation, and Response Criteria Harmonization (SEARCH) for Childhood, Adolescent, and Young Adult Hodgkin Lymphoma (CAYAHL) Group
Matthew D.HallMD, MBA*Stephanie A.TerezakisMD†John T.LucasJr, MS, MD‡EveGallop-EvansMD§KarinDieckmannMDâ•‘Louis S.ConstineMD¶DavidHodgsonMD, MPH, FRCPC#Jamie E.FlerlageMD, MSâ�Žâ�ŽMonika L.MetzgerMDâ�Žâ�ŽBradford S.HoppeMD, MPH†â€
Bicentric Treatment Outcomes After Proton Therapy for Nonmyxopapillary High-Grade Spinal Cord Ependymoma in Children
Daniel J.IndelicatoMD*MyrsiniIoakeim-IoannidouMD†Adam J.GrippinPhD*Julie A.BradleyMD*Raymond B.Mailhot VegaMD*EmmaViviersMS*Nancy J.TarbellMD†Torunn I.YockMD†Shannon M.MacDonaldMDâ€
Hypofractionated Stereotactic Radiation Therapy for Intact Brain Metastases in 5 Daily Fractions: Effect of Dose on Treatment Response
StenMyrehaugMD, FRCPC�JohnHudsonMD, PhD*HanySolimanMD*MarkRuschinPhD†Chia-LinTsengMD*JayDetskyMD, PhD*ZainHusainMD*JuliaKeithMD‡Eshetu G.AtenafuMSc, PStat§PejmanMaralaniMD‖ChrisHeynMD, PhD‖SunitDasMD, PhD¶NirLipsmanMD, PhD#ArjunSahgalMD*
International Multi-institutional Patterns of Contouring Practice and Clinical Target Volume Recommendations for Stereotactic Body Radiation Therapy for Non-Spine Bone Metastases
Timothy K.NguyenMD*LeeChinPhD†ArjunSahgalMD†RoiDaganMD, MS‡WietseEppingaMD§MatthiasGuckenbergerMDâ•‘Jin HoKimMD, PhD¶Simon S.LoMD#Kristin J.RedmondMD, MPHâ�Žâ�ŽShankarSivaMBBS, PhD††Bradley J.StishMD‡‡RachelChanPhD§§LiamLawrenceMAScâ•‘â•‘AngusLauPhD§§║║Chia-LinTsengMDâ€
American Radium Society Appropriate Use Criteria for Radiation Therapy in Oligometastatic or Oligoprogressive Non-Small Cell Lung Cancer
AryaAminiMD*VivekVermaMD†Charles B.SimoneIIMD‡§Indrin J.ChettyPhDâ•‘Stephen G.ChunMD†JessicaDoningtonMD#Martin J.EdelmanMDâ�Žâ�ŽKristin A.HigginsMD††Larry L.KestinMD‡‡BenjaminMovsasMDâ•‘George B.RodriguesMD§§Kenneth E.RosenzweigMDâ•‘â•‘Igor I.RybkinMD, PhDâ•‘Benjamin J.SlotmanMD, PhD##AndreaWolfMDâ•‘â•‘Joe Y.ChangMD, PhDâ€
Cautioning Against Declaring Success Before the Finish Line
Michael T.MilanoMD, PhD*Steven J.ChmuraMD, PhDâ€
Phase I Trial of Stereotactic MRI-Guided Online Adaptive Radiation Therapy (SMART) for the Treatment of Oligometastatic Ovarian Cancer
Lauren E.HenkeMD, MSCI*Jennifer A.StanleyMD, PhD*CliffordRobinsonMD*AmarSrivastavaMD, MPH*Jessika A.ContrerasMD*AustenCurcuruMS*Olga L.GreenPhD*L. StewartMassadMD†LindsayKurokiMD†KatherineFuhMD, PhD†AndreaHagemannMD, MSCI†DavidMutchMD†CarolynMcCourtMD†PremalThakerMD†MatthewPowellMD†StephanieMarkovinaMD, PhD*Perry W.GrigsbyMD, MBA*Julie K.SchwarzMD, PhD*AnupamaChunduryMD‡
Radiation Therapy Techniques and Treatment-Related Toxicity in the PORTEC-3 Trial: Comparison of 3-Dimensional Conformal Radiation Therapy Versus Intensity-Modulated Radiation Therapy
Bastiaan G.WortmanMD*Cathalijne C.B.PostMD*Melanie E.PowellMD, PhD†PearlyKhawMD, PhD‡AnthonyFylesMD, PhD§RomeraiD'AmicoMD, PhD‖ChristineHaie-MederMD, PhD¶Ina M.Jürgenliemk-SchulzMD, PhD#MaryMcCormackMD, PhD��VietDoMD, PhD††DionyssiosKatsarosMD, PhD‡‡PaulBessetteMD, PhD§§Marie HélèneBaronMD, PhD‖‖Remi A.NoutMD, PhD*KarenWhitmarshMD, PhD¶¶LindaMileshkinMD, PhD##Ludy C.H.W.LutgensMD, PhD���Henry C.KitchenerMD, PhD†††…Stephanie M.de BoerMD, PhD*
Impact of Vaginal Symptoms and Hormonal Replacement Therapy on Sexual Outcomes After Definitive Chemoradiotherapy in Patients With Locally Advanced Cervical Cancer: Results from the EMBRACE-I Study
KathrinKirchheinerMSc, PhD*StéphanieSmetMD†‡Ina M.Jürgenliemk-SchulzMD, PhD§ChristineHaie-MederMD, PhD||CyrusChargariMD, PhD||Jacob C.LindegaardMD, DMSc¶Lars U.FokdalMD, PhD¶SofiaSpampinatoMSc, PhD¶Maximilian P.SchmidMD*AlinaSturdzaMD, FRCPC*UmeshMahantshettyDMRT, MD, DNB#BarbaraSegedinMD, PhD��KjerstiBruheimMD, PhD††BhavanaRaiMD, DNB‡‡RachelCooperMD, FRCR§§ElzbietaVan der Steen-BanasikMD|| ||ErickaWiebeMD¶¶MaritSundsetMD##…Remi A.NoutMD, PhD|| || ||
Secondary Prevention, Not Secondary Importance: Embracing Survivorship Concerns and HRT After Cervical Cancer Radiation Therapy
ShariDamastMDâ�ŽJunzoChinoMDâ€
Cardiac Magnetic Resonance Imaging and Blood Biomarkers for Evaluation of Radiation-Induced Cardiotoxicity in Patients With Breast Cancer: Results of a Phase 2 Clinical Trial
CoreySpeersMD, PhDâ�Žâ€ Venkatesh L.MurthyMD‡§Eleanor M.WalkerMDâ•‘Carri K.Glide-HurstPhD¶RobinMarshCMDâ�ŽMingTangMS#Emily L.MorrisPhD#Matthew J.SchipperPhDâ�Ž#Richard L.WeinbergMD, PhD‡§Hunter C.GitsMDâ�Žâ�ŽJamesHaymanMDâ�Žâ€ MaryFengMD††JamesBalterPhD*JeanMoranPhD*ReshmaJagsiMD, DPhilâ�Žâ€ Lori J.PierceMDâ�Žâ€
Outcomes After Breast Radiation Therapy in a Diverse Patient Cohort With a Germline BRCA1/2 Mutation
Bhavana V.ChapmanMD*DianeLiuMS†YuShenPhD†Oluwafikayo O.OlamigokeBS*David S.LakomyMD*Angelica M. GutierrezBarreraMS‡Shane R.SteckleinMD, PhD*Gabriel O.SawakuchiPhD§Scott J.BrightPhD§IsabelleBedrosianMD║Jennifer K.LittonMD‡Benjamin D.SmithMD*Wendy A.WoodwardMD, PhD*George H.PerkinsMD*Karen E.HoffmanMD, MHSc, MPH*Michael C.StauderMD*Eric A.StromMD*Banu K.ArunMD‡Simona F.ShaitelmanMD, EdM*
Breast Radiation Therapy–Related Treatment Outcomes in Patients With or Without Germline Mutations on Multigene Panel Testing
Bhavana V.ChapmanMD*DianeLiuMS†YuShenPhD†Oluwafikayo O.OlamigokeBS*David S.LakomyMD*Angelica M. GutierrezBarreraMS‡Shane R.SteckleinMD, PhD*Gabriel O.SawakuchiPhD§Scott J.BrightPhD§IsabelleBedrosianMD‖Jennifer K.LittonMD‡Benjamin D.SmithMD*Wendy A.WoodwardMD, PhD*George H.PerkinsMD*Karen E.HoffmanMD, MHSc, MPH*Michael C.StauderMD*Eric A.StromMD*Banu K.ArunMD‡Simona F.ShaitelmanMD, EdM*
Influence of Hypofractionated Versus Conventional Fractionated Postmastectomy Radiation Therapy in Breast Cancer Patients With Reconstruction
Dong-YunKimMD*EonjuParkMD†Chan YeongHeoMD, PhD†Ung SikJinMD, PhD†Eun KyuKimMD, PhD‡WonshikHanMD, PhD‡§Kyung HwanShinMD, PhD*In AhKimMD, PhD�§║
Increasing Demand on Human Capital and Resource Utilization in Radiation Therapy: The Past Decade
KundanThindPhD�†‡MichaelRoumeliotisPhD�†‡ThomasMannBSc†‡LukasVan DykeBSc‡KevinMartellMD�‡WendySmithPhD�†‡LisaBarberaMD�‡SarahQuirkPhD�†‡
Diaphragm-Based Position Verification to Improve Daily Target Dose Coverage in Proton and Photon Radiation Therapy Treatment of Distal Esophageal Cancer
SabineVisserBSc1Lydia A.den OtterPhD1Cássia O.RibeiroPhDErik W.KorevaarPhDStefanBothPhDJohannes A.LangendijkMD, PhDChristina T.MuijsMD, PhDNanna M.SijtsemaPhD1AntjeKnopfPhD1
Boosting the Abscopal Effect Using Immunogenic Biomaterials With Varying Radiation Therapy Field Sizes
SayedaYasmin-KarimPhD�BashkimZiberiPhD†‡JohannaWirtz†§NoellaBihBS�MicheleMoreauMS�║��RomyGuthierPhD�¶VictoriaAinsworthMS†║JuergenHesserPhD¶G. MikeMakrigiorgosPhD�Michael D.ChuongMD#XiaoWeiMD�Paul L.NguyenMD�WilfredNgwaPhD�║��
Therapy-Naive and Radioresistant 3-Dimensional Pancreatic Cancer Cell Cultures Are Effectively Radiosensitized by β1 Integrin Targeting
JosephineGörtePhD�†ErikDanenPhD‡NilsCordesMD, PhD�†§║
Radioresistance and Transcriptional Reprograming of Invasive Glioblastoma Cells
ZiliTangMBBS, PhD�†‡§‖IvanaDokicPhD�†‡§‖MaximilianKnollMD, PhD�†‡§‖FedericaCiamarone�†‡§‖#ChristianSchwagerPhD�†‡§‖CarmenKleinPhD�†‡§‖GinaCebulla†§‖#Dirk C.Hoffmann†§‖#JulianSchlegelPhD�†‡§‖PhilippSeidelPhD�†‡§‖ChristianeRutenberg*†‡§‖StephanBronsPhD‡‖ChristelHerold-MendePhD†§‖WolfgangWickMD†§‖JürgenDebusMD, PhD�†‡§‖DieterLemkeMD†§‖1AmirAbdollahiMD, PhD�†‡§‖1
Activated B Cells and Plasma Cells Are Resistant to Radiation Therapy
IdaFraniak-PietrygaPhD*SayuriMiyauchiPhD*Sangwoo ShawnKim*Philip DominickSandersBS�WhitneySumner*LinZhangPhD*A.J.MundtPhD*Joseph A.CalifanoPhD*†Andrew B.SharabiPhD*
Radiosensitivity-Specific Proteomic and Signaling Pathway Network of Non-Small Cell Lung Cancer (NSCLC)
XueruZhuMD, PhD*1YitingWangMD, PhD*1ChangJiangMD*1XiaoyangLiMD, PhD†LinyingSunMD‡GuangzhongWangMD, PhD‡XiaolongFuMD, PhD�
A Novel Role for RNF126 in the Promotion of G2 Arrest via Interaction With 14-3-3σ
PengyanFaMS*ZhaojunQiuPhD*Qi-EnWangPhD*ChunhongYanPhD†JunranZhangMD, PhD*
Cognitive and Imaging Differences After Proton and Photon Whole Brain Irradiation in a Preclinical Model
Tien T.TangPhD*Janice A.ZawaskiPhD*ShelliKeslerPhD†Christine A.BeamishPhD‡TaekoInouePhD*Emma C.PerezPhD*LawrenceBronkPhD§FalkPoenischPhD‖Tina M.BrierePhD‖Omaima M.SabekPhD‡David R.GrosshansMD, PhD§M.Waleed GaberPhD�¶
Brachial Plexus Tolerance to Single-Session SABR in a Pig Model
BrianHrycushkoPhD*Albert J.van der KogelPhD†LaurenPhillipsMD‡AvneeshChhabraMD, MBA§Michael R.FolkertMD, PhD*James W.SayrePhD‖¶StevenVerninoMD, PhD‡NimaHassan-RezaeianPhD#YoshiyaYamadaMD��RobertTimmermanMD*Paul M.MedinPhD�
In Regard to Chang et al
YudaiTateishiMD1AtsuyaTakedaMD, PhD2NobuyukiHoritaMD, PhD3
Timeliness of Lung Cancer Care From the Point of Suspicious Image at an Urban Safety Net Hospital by Demographic and Clinical Factors
N.SiddiqiY.LinK.JenkinsG.PanA.LiuK.S.MakU.TapanK.Suzuki
Use of AVATS, Awake Video Assisted Thoracic Surgery, to Redefine Operability in Lung Cancer Patients With Extremely Poor Pulmonary Function
A.S.Klijian1K.Bagheri2
A Nested Case-Control Study of Lung Cancer for Immune Biomarkers
U.Sivagnanalingam12P.L.Beatty2C.Jacqueline2M.Dracz2J.Adams-Haduch3R.Wang3J.M.Yuan34O.J.Finn23
Toxicity and Survival Outcomes From Intensity Modulated Proton Therapy-Based Re-Irradiation in Patients With Non-Small Cell Lung Cancer
P.Mohindra12A.Saeed1M.A.L.Vyfhuis23K.Scilla4J.K.Molitoris12C.B.SimoneII56C.Rolfo7R.Mehra4
Impact of Mesothelioma Histologic Subtype and Use of Cancer-Directed Surgery on Outcomes in the National Cancer Database
A.MansurA.PotterR.MeyerhoffM.LanutiC.F.J.Yang
Hot Spot Not Hot Enough? Differences in Local Control for Non-Small Cell Lung Cancer Treated With Stereotactic Body Radiotherapy Based on Maximum Point Dose within the Planning Target Volume
E.L.BraschiA.N.De LeoC.G.MorrisA.R.Yeung
FLT-PET/CT in Non-Small Cell Lung Cancer Treated With SBRT- A Pilot Study
S.C.Lewis12A.J.Hope3M.Chan4J.Weiss5H.Raziee1A.Bezjak6J.Cho7A.Sun1B.H.Lok8S.Raman1J.P.Bissonnette9D.Vines10M.E.Giuliani1
Comparison of National Comprehensive Cancer Network and American College of Surgeons Commission on Cancer Lymph Node Sampling Guidelines for Non-Small Cell Lung Cancer
B.Heiden12D.Eaton3S.H.Chang23Y.Yan23M.Schoen34B.Meyers1B.Kozower1V.Puri13
Tepotinib in Patients with Advanced NSCLC with MET Amplification (METamp)
X.Le1R.O'Hara2L.Paz-Ares3J.P.Van Meerbeeck4S.Viteri Ramirez56C.Cabrera Galvez7D.Vincente Baz8Y.C.Kim9J.H.Kang10K.M.Schumacher11N.Karachaliou11S.Adrian11R.Bruns12P.Paik1314
Prospective Evaluation of Limited Stage Small Cell Lung Cancer (LS-SCLC) Fractionation Regimen Usage and Toxicity in a Large Statewide Quality Collaborative
S.G.Allen1A.F.Dragovic1H.Yin2A.K.Bryant1P.Paximadis3M.M.Matuszak1M.Schipper4R.T.Dess1J.A.Hayman1M.M.Dominello5L.L.Kestin6I.S.Grills7B.Movsas8S.Jolly1D.P.Bergsma1
Impact of Cardiac Dose on Overall Survival in Lung Stereotactic Body Radiotherapy (SBRT) Compared to Conventionally Fractionated Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC)
J.Anderson1M.Fatyga2S.E.Schild3J.Li4J.Hu5
Effect of Antibiotic Therapy on Immunotherapy Outcomes for Non-Small Cell Lung Cancer: Analysis From the Veterans Health Administration
W.A.Stokes12M.Behera1R.Jiang1D.A.Gutman3Z.Huang1A.Burns3N.Sebastian2V.V.Sukhatme4M.Lowe15S.Ramalingam16V.P.Sukhatme4D.Moghanaki7
Plasma Cell-Free RNA PD-L1 Expression and Clinical Outcomes With Immunotherapy
S.JayanandaM.MuzaffarP.NamireddyN.SharmaP.Walker
DREAM3R: DuRvalumab With chEmotherapy as First Line treAtment in Advanced Pleural Mesothelioma: A Phase 3 Randomised Trial
P.Forde1H.Kindler2M.Zauderer3Z.Sun4S.Ramalingam5V.Anagnostou6J.R.Brahmer7A.K.Nowak8P.S.Kok9C.Brown9S.Yip9A.Cook10W.J.Lesterhuis11B.G.M.Hughes12N.Pavlakis13M.R.Stockler14K.J.O'Byrne15
Salvage Radiosurgery for Recurrent Cardiac Sarcoma: A Case Report
S.N.Shah1W.Knotts2S.A.Shah1
Surgical Outcomes for Early-Stage Non-Small Cell Lung Cancer at Facilities With Stereotactic Body Radiation Therapy Programs
Y.A.Syed1W.A.Stokes2M.Rupji3Y.Liu4O.Khullar5N.Sebastian2K.A.Higgins6J.D.Bradley7W.J.CurranJr6S.Ramalingam8J.Taylor9M.Sancheti5F.Fernandez2D.Moghanaki10
Accounting for Operability Status in Retrospective Comparisons of Surgery vs. SBRT for Early-Stage NSCLC
J.Lorenz1D.Moghanaki2H.Keshava3D.H.Harpole4J.D.Bradley5K.A.Higgins6C.G.RusthovenJr7W.A.Stokes8
Prediction of Regional and Distant Failure After Definitive Thoracic Stereotactic Body Radiation Therapy (SBRT) Using Pre-Treatment CT-Based Radiomic Analysis
J.Bae1E.Zabrocka2C.Rodriguez1D.L.Payne3R.Cattell1S.Ryu1P.Prasanna2K.M.Mani1
Dosimetric Comparison of Arms Up Versus Arms Down Positions for Lung SBRT
T.CarpenterJ.P.SantoroJ.W.LischalkD.W.EblingM.C.RepkaM.WittenJ.A.Haas
Comparing Clinicopathologic Factors and Survival in Stage III Adenocarcinoma and Squamous Cell Carcinoma of the Lung Following Definitive Chemoradiotherapy
S.Abel1A.Colonias1S.Beriwal1B.Weksler2G.Finley3S.Long3R.E.Wegner1
IGNYTE: A Phase 1/2 Multi-Cohort Clinical Trial of RP1 ± Nivolumab in Patients with Non-Small Cell Lung Cancer and Other Solid Tumors
H.Emamekhoo1S.Patel2E.Rodriguez3M.K.Riaz4G.Giaccone5M.Furqan6J.J.Sacco7P.Bommareddy8S.Raza8S.He8K.Harrington9M.R.Middleton10
METex14 ctDNA Dynamics & Resistance Mechanisms Detected in Liquid Biopsy (LBx) From Patients (pts) With METex14 Skipping NSCLC Treated With Tepotinib
P.Paik23R.O'Hara1R.Veillon4E.Felip5A.Cortot6H.Sakai7J.Mazières8M.Thomas9N.Reinmuth10J.Raskin11P.Conte12M.Garassino13W.T.Iams14F.Griesinger15D.Kowalski16C.Stroh17D.Juraeva18J.Scheuenpflug19…X.Le21
Upfront Treatment With Osimertinib vs. Osimertinib and Radiotherapy for Patients With EGFR-Positive Non-Small Cell Lung Cancer Brain Metastases
A.E.Dohm1J.Tang2M.N.Mills1B.A.Perez2T.J.Robinson1B.Creelan2H.H.M.Yu1D.E.Oliver1K.A.Ahmed1
Intracranial Activity of Tepotinib in Patients (pts) With MET exon 14 (METex14) Skipping NSCLC Enrolled in VISION
C.M.Bestvina1J.D.Patel2X.Le3R.Veillon4I.Anderson5I.Demedts6M.Garassino7J.Mazières8M.Morise9E.Smit10S.P.Eggleton11A.O'Brate12G.Otto13R.Bruns14K.M.Schumacher13P.Paik1516
A Multi-Center, Open-Label, Randomized, Two-Arm Study, to Evaluate the Efficacy of Osimertinib with Early Intervention SRS Treatment Compared to the Continuation of Osimertinib Alone, in Patients with EGFR-Mutated NSCLC and Asymptomatic Brain Metastases
P.A.Blumenfeld1G.Marwaha2Y.Shoshan1J.Feldman1H.Nechushtan1Y.Rottenberg1N.Hirsch1K.Sheva1A.Meirovitz1
Racial Disparities in Treatment and Outcome of Non-Small Cell Lung Cancer (NSCLC) Patients Across Different Facility Types
F.Zhu1J.Shogan2H.Wang1H.Ashamalla1
A Comparison of Overall Patient Reported Distress Levels in Appalachian Cancer Patients From Economically Distressed vs. Non-Economically Distressed Counties Receiving Radiation Therapy for Thoracic Malignancies
K.Finnegan1N.St.Thomas1D.Rosenweig2R.C.Miller3
Implementation of Standardized Lecture to Improve Radiation Oncology Knowledge in Multidisciplinary Lung Cancer Care Team: Initial Results of a Multi-Institutional Pilot Study
J.C.Ye1F.F.Rizvi2G.Welch3T.O.ThomasJr4E.Weiss5R.A.Chandra6S.Gutiontov7S.B.Motwani8M.D.Mattes9
Impact of Radiation Therapy on Inpatient Outcomes Among Patients With Lung Cancer
C.R.Mudigonda1C.Davila-Chapa1P.Gutta1H.P.Patel2U.Grewal1K.Beedupalli1
Sarcoidosis or Sarcoid Reaction With Lung Cancer in Ethnic Han Chinese Patients: A Single Center Experience and Literature Review
X.He
Indirect Treatment Comparison of Lurbinectedin vs. Other Second-Line Treatments for Small-Cell Lung Cancer
B.Rengarajan1R.Hanvesakul2C.Stack3F.Wilson4J.Park4A.Adeyemi4
End of Life Care in Hospitalized Patients With Lung Cancer
T.S.Brown1U.Grewal1S.R.Thotamgari2A.K.Ananthaneni2C.Burnett2S.Vutukuri2K.Beedupalli1
Comprehensive Analyses Identify a Signature Based on Pyroptosis-Related Genes for Breast Cancer
Y.Zhou12J.Zheng3N.Lin12
